Nippon India Pharma Fund Bonus
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Bonus
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 10-May-2004
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8346.49
Nippon India Pharma Fund Bonus - Nav Details
Nav Date
: 09-Dec-2025
NAV [Rs.]
: 508.2588
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
:
Nippon India Pharma Fund Bonus- NAV Chart
Nippon India Pharma Fund Bonus- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -1.25 | -0.24 | -0.43 | 0.29 | -1.36 | 21.26 | 15.75 | 20.04 |
| Category Avg | -1.82 | -1.42 | -1.1 | 1.74 | -1.82 | 22.44 | 16.33 | 13.92 |
| Category Best | -0.84 | 0.89 | 1.21 | 6.02 | 4.5 | 27.98 | 19.08 | 29.41 |
| Category Worst | -3.34 | -3.09 | -3.01 | -4.4 | -9.05 | 18.52 | 12.06 | -5.46 |
Nippon India Pharma Fund Bonus- Latest Dividends
No Records Found
Nippon India Pharma Fund Bonus- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 13.55 | 6256349 | 1,145.91 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 7.59 | 3083991 | 642.14 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 6.90 | 900754 | 583.41 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.33 | 3495054 | 535.19 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.83 | 3916074 | 492.95 |
| Equity | Apollo Hospitals | Healthcare Services | 5.63 | 648795 | 475.92 |
| Equity | Medplus Health | Retailing | 3.47 | 3627277 | 293.37 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.41 | 2886684 | 288.10 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 2.90 | 959323 | 245.66 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.77 | 913226 | 234.65 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.75 | 1320549 | 232.36 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.67 | 2555745 | 226.03 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.57 | 4392120 | 217.71 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.47 | 1702630 | 208.86 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.44 | 68677 | 206.54 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.20 | 609112 | 185.88 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.18 | 323678 | 184.01 |
| Equity | Narayana Hrudaya | Healthcare Services | 2.12 | 923911 | 179.74 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.09 | 999649 | 177.06 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.02 | 757496 | 170.51 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.99 | 4219374 | 168.07 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.93 | 1124164 | 163.35 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.87 | 318249 | 158.32 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.35 | 3896349 | 114.04 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.24 | 740259 | 104.69 |
| Equity | Max Healthcare | Healthcare Services | 1.23 | 891340 | 103.64 |
| Equity | Fortis Health. | Healthcare Services | 1.20 | 1103889 | 101.45 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.19 | 230272 | 101.03 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.18 | 213659 | 99.55 |
| Equity | Syngene Intl. | Healthcare Services | 0.98 | 1280492 | 83.01 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.79 | 1058503 | 67.18 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.76 | 1515264 | 64.54 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.67 | 62568 | 56.46 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.56 | 1834924 | 47.00 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.45 | 457561 | 38.12 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.19 | 111738 | 15.84 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,63,683.95
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
